CIK 0001806540
Lycia Therapeutics, Inc.
Sign in to watch- Ticker
- LYCA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- other
- EIN
- 843860514
- Phone
- (650) 392-3357
- Business address
- 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $38,522,394
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,522,394. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-22 | Fischer Laurent Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-10-22 | RIEFLIN WILLIAM JL Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-08-11 | Touami Sofia Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +68,755 | 68,755 | ||
| 2026-08-11 | Staben Steven Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +110,896 | 110,896 | ||
| 2026-08-11 | Bachrodt Amy Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +399,746 | 399,746 | ||
| 2026-08-11 | Lee Chin Hyok Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +73,191 | 73,191 | ||
| 2026-08-11 | Trombley Aetna Wun President and CEO | Grant or award · Stock Option (Right to Buy) | +443,586 | 443,586 | ||
| 2026-08-11 | Henderson Jane Director | Grant or award · Stock Option (Right to Buy) | +57,666 | 57,666 | ||
| 2026-08-11 | Fischer Laurent Director | Grant or award · Stock Option (Right to Buy) | +13,307 | 13,307 | ||
| 2026-08-11 | RIEFLIN WILLIAM JL Director | Grant or award · Stock Option (Right to Buy) | +24,840 | 24,840 |
Page 2 of 2 · 30 trades